Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/2
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Jul 09, 2025Jul 11, 2025Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$15.69$474,698-19.12%
May 23, 2025May 27, 2025Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$11.31$21,782-1.92%
May 22, 2025May 23, 2025Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$11.88$27,516-2.33%
May 19, 2025May 20, 2025Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$11.84$30,791-2.65%
Feb 24, 2025Feb 26, 2025Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$10.02$19,218-2.00%
Feb 18, 2025Feb 20, 2025Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$9.82$25,553-2.73%
Nov 26, 2024Nov 28, 2024Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$9.87$19,378-2.11%
Nov 18, 2024Nov 20, 2024Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$9.26$66,573-7.40%
Aug 23, 2024Aug 26, 2024Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$12.4$23,758-2.19%
Aug 19, 2024Aug 22, 2024Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$12.01$85,318-7.76%
May 20, 2024May 21, 2024Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$11.76$136,586-12.66%
Feb 20, 2024Feb 22, 2024Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$14.11$170,124-14.19%
Feb 14, 2024Feb 16, 2024Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$15.01$598,661-37.61%
Nov 20, 2023Nov 21, 2023Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$8.23$58,535-13.38%
Aug 18, 2023Aug 22, 2023Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$10.73$76,624-14.63%
May 18, 2023May 20, 2023Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$10.14$26,416-6.52%
Feb 17, 2023Feb 23, 2023Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$7.66$20,889-7.09%
Nov 18, 2022Nov 21, 2022Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$5.44$6,196-3.22%
Aug 17, 2022Aug 19, 2022Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$14.96$17,130-3.30%
Nov 01, 2021Nov 03, 2021Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$18.07$90,328-13.17%
Aug 02, 2021Aug 04, 2021Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$20.52$102,579-11.64%
May 03, 2021May 07, 2021Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$24.84$124,197-10.42%
Feb 23, 2021Feb 26, 2021Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$33.59$503,877-23.82%
Oct 29, 2020Nov 03, 2020Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$17.48$87,394-7.36%
Oct 20, 2020Oct 22, 2020Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$17.82$249,167-17.07%
Oct 16, 2020Oct 20, 2020Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$17$15,539-1.10%
Feb 05, 2020Feb 07, 2020Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$17.1$1,710-0.12%
Dec 20, 2019Dec 26, 2019Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$17.02$45,025-3.09%
Dec 12, 2019Dec 17, 2019Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$17.05$80,269-5.37%
Jul 22, 2019Jul 24, 2019Yea Christopher
Chief Development Officer
SellKalvista Pharmaceuticals, Inc.KALV$18.35$134,930-8.14%